-
1Academic Journal
Authors: Avazova, Nilufar, Rizvonov, Jasur, Tojibayeva, Dildora
Source: Medical science of Uzbekistan; No. 3 (2025): May-June; 43-46 ; Медицинская наука Узбекистана; № 3 (2025): Май-Июнь; 43-46 ; O`zbekiston tibbiyot ilmi; No. 3 (2025): May-Iyun; 43-46 ; 2181-3612
Subject Terms: diabetes mellitus, diabetic neuropathy, peripheral neuropathy, distally symmetrical polyneuropathy, neurological complications, neuropathic pain, treatment, диабет, диабетическая невропатия, периферическая невропатия, дистально-симметричная полинейропатия, неврологические осложнения, невропатическая боль, лечение, qandli diabet, diabetik neyropatiya, periferik neyropatiya, distal simmetrik polineyropatiya, nevrologik asoratlar, neyropatik og‘riq, davolash
File Description: application/pdf
Relation: https://fdoctors.uz/index.php/journal/article/view/158/121; https://fdoctors.uz/index.php/journal/article/view/158
-
2Academic Journal
Authors: O.A. Halushko
Source: МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16, № 3 (2020); 37-46
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16, № 3 (2020); 37-46
EMERGENCY MEDICINE; Том 16, № 3 (2020); 37-46Subject Terms: 03 medical and health sciences, 0302 clinical medicine, цукровий діабет, діабетична нейропатія, анестезія, моніторинг, diabetes mellitus, diabetic neuropathy, anesthesia, monitoring, сахарный диабет, диабетическая невропатия, анестезия, мониторинг, 3. Good health
File Description: application/pdf
-
3Report
Subject Terms: lifestyle, диабетическая невропатия, cardiovascular complications, управление диабетом, prediabetes, сахарный диабет 2 типа, diabetes management, кардиоваскулярные осложнения, медикаментозная терапия, лечение диабета, insulin resistance, предиабет, metabolic disorders, мониторинг глюкозы, диабетическая нефропатия, diabetes treatment, diabetic nephropathy, diabetes complications, гипергликемия, диабетическая ретинопатия, diabetic neuropathy, drug therapy, diabetic retinopathy, glucose monitoring, образ жизни, инсулинорезистентность, type 2 diabetes, hyperglycemia, метаболические нарушения, осложнения диабета
-
4Academic Journal
Authors: O. E. Zinovyeva, T. M. Ostroumova, M. V. Koniashova, N. A. Gorbachev, О. Е. Зиновьева, Т. М. Остроумова, М. В. Коняшова, Н. А. Горбачев
Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 13, No 5 (2021); 116-122 ; Неврология, нейропсихиатрия, психосоматика; Vol 13, No 5 (2021); 116-122 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2021-5
Subject Terms: альфа-липоевая кислота, diabetic neuropathy, peripheral nervous system, alpha-lipoic acid, диабетическая невропатия, периферическая нервная система
File Description: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/1675/1320; Шестакова МВ, Викулова ОК, Железнякова АВ и др. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие? Терапевтический архив. 2019;91(10):4-13. doi:10.26442/00403660.2019.10.000364; Дедов ИИ, Шестакова МВ, Майоров АЮ и др. Сахарный диабет 2 типа у взрослых. Сахарный диабет. 2020;23(2S):4-102. doi:10.14341/DM12507; Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020 Jan 7;41(2):255-323. doi:10.1093/eurheartj/ehz486; International Diabetes Federation. IDF Diabetes Atlas, 9 th ed. Brussels, Belgium: 2019. Available from: https://www.diabetesatlas.org; Pfannkuche A, Alhajjar A, Ming A, et al. Prevalence and risk factors of diabetic peripheral neuropathy in a diabetics cohort: Register initiative «diabetes and nerves». Endocr Metab Sci. 2020 Jul;1(1-2):100053. doi:10.1016/j.endmts.2020.100053; Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017 Sep;8(5):646-55. doi:10.1111/jdi.12650; Kirthi V, Perumbalath A, Brown E, et al. Prevalence of peripheral neuropathy in pre-diabetes: a systematic review. BMJ Open Diabetes Res Care. 2021 May;9(1):e002040. doi:10.1136/bmjdrc-2020-002040; American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes – 2021. Diabetes Care. 2021 Jan;44(Suppl. 1):S15-S33. doi:10.2337/dc21-S002; Barrell K, Smith AG. Peripheral Neuropathy. Med Clin North Am. 2019 Mar;103(2):383-97. doi:10.1016/j.mcna.2018.10.006; Ziegler D, Rathmann W, Dickhaus T, et al. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2008 Mar;31(3):464-9. doi:10.2337/dc07-1796; Kazamel M, Stino AM, Smith AG. Metabolic syndrome and peripheral neuropathy. Muscle Nerve. 2021 Mar;63(3):285-93. doi:10.1002/mus.27086; Ziegler D, Rathmann W, Dickhaus T, et al. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009 Mar;10(2):393-400. doi:10.1111/j.1526-4637.2008.00555.x; Lee CC, Perkins BA, Kayaniyil S, et al. Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort. Diabetes Care. 2015 May;38(5):793-800. doi:10.2337/dc14-2585; Spallone V. Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet. Diabetes Metab J. 2019 Feb;43(1):3-30. doi:10.4093/dmj.2018.0259; Ziegler D, Voss A, Rathmann W, et al. Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey. Diabetologia. 2015 May;58(5):1118-28. doi:10.1007/s00125-015-3534-7; Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136-54. doi:10.2337/dc16-2042; Дедов ИИ, Шестакова МВ, Майоров АЮ, редакторы. Алгоритмы специализированной медицинской помощи больным сахарным диабетом: Клинические рекомендации. 9-й выпуск. Сахарный диабет. 2019;22(1S1):1-144. doi:10.14341/DM221S1; American Diabetes Association. Microvascular complications and foot care: Standards of Medical Care in Diabetes – 2021. Diabetes Care. 2021 Jan;44(Suppl. 1):S151-S167. doi:10.2337/dc21-S011; Papanas N, Ziegler D. Prediabetic neuropathy: does it exist? Curr Diab Rep. 2012 Aug;12(4):376-83. doi:10.1007/s11892-012-0278-3; Zeng J, Xu Y, Shi Y, Jiang C. Inflammation role in sensory neuropathy in Chinese patients with diabetes/prediabetes. Clin Neurol Neurosurg. 2018 Mar;166:136-40. doi:10.1016/j.clineuro.2018.01.031; Van der Velde JHPM, Koster A, Strotmeyer ES, et al. Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study. Diabetologia. 2020 Aug;63(8):1648-58. doi:10.1007/s00125-020-05194-5; Kopf S, Groener JB, Kender Z, et al. Deep phenotyping neuropathy: An underestimated complication in patients with pre-diabetes and type 2 diabetes associated with albuminuria. Diabetes Res Clin Pract. 2018 Dec;146:191-201. doi:10.1016/j.diabres.2018.10.020; Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Contribution of QSART to the diagnosis of small fiber neuropathy. Muscle Nerve. 2013 Dec;48(6):883-8. doi:10.1002/mus.23891; McArthur JC. Painful small fiber neuropathies. Continuum (Minneap Minn). 2012 Feb;18(1):106-25. doi:10.1212/01.CON.0000411570.79827.25; Divisova S, Vlckova E, Hnojcikova M, et al. Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres. J Peripher Nerv Syst. 2012 Sep;17(3):341-50. doi:10.1111/j.1529-8027.2012.00420.x; Asghar O, Petropoulos IN, Alam U, et al. Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care. 2014 Sep;37(9):2643-6. doi:10.2337/dc14-0279; DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011 Mar;37(3):588-98. doi:10.1016/j.jcrs.2010.12.037; Jende JME, Kender Z, Mooshage C, et al. Diffusion Tensor Imaging of the Sciatic Nerve as a Surrogate Marker for Nerve Functionality of the Upper and Lower Limb in Patients With Diabetes and Prediabetes. Front Neurosci. 2021 Mar;15:642589. doi:10.3389/fnins.2021.642589; Suo M, Wang P, Zhang M. Role of Fyn-mediated NMDA receptor function in prediabetic neuropathy in mice. J Neurophysiol. 2016 Aug;116(2):448-55. doi:10.1152/jn.00229.2016; Hinder LM, O'Brien PD, Hayes JM, et al. Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome. Dis Model Mech. 2017 Jun;10(6):717-25. doi:10.1242/dmm.028530; Roncero-Ramos I, Alcala-Diaz JF, Rangel-Zuniga OA, et al. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study. Clin Nutr. 2020 Feb;39(2):492-500. doi:10.1016/j.clnu.2019.02.027; Hemmingsen B, Gimenez-Perez G, Mauricio D, et al. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD003054. doi:10.1002/14651858.CD003054.pub4; Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-61. doi:10.1016/S2213-8587(19)30093-2; Nathan DM, Barrett-Connor E, Crandall JP, et al. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866-75. doi:10.1016/S2213-8587(15)00291-0; Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006 Jun;29(6):1294-9. doi:10.2337/dc06-0224; Groover AL, Ryals JM, Guilford BL, et al. Exercise-mediated improvements in painful neuropathy associated with prediabetes in mice. Pain. 2013 Dec;154(12):2658-67. doi:10.1016/j.pain.2013.07.052; Carnethon MR, Prineas RJ, Temprosa M, et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006 Apr;29(4):914-9. doi:10.2337/diacare.29.04.06.dc05-1729; Madsen KS, Chi Y, Metzendorf MI, et al. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Database Syst Rev. 2019 Dec;12(12):CD008558. doi:10.1002/14651858.CD008558.pub2; Moelands SV, Lucassen PL, Akkermans RP, et al. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2018 Dec;12(12):CD005061. doi:10.1002/14651858.CD005061.pub3; Hemmingsen B, Sonne DP, Metzendorf MI, Richter B. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017 May;5(5):CD012204. doi:10.1002/14651858.CD012204.pub2; Infante M, Leoni M, Caprio M, Fabbri A. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind. World J Diabetes. 2021 Jul;12(7):916-31. doi:10.4239/wjd.v12.i7.916; Inzucchi SE, Docherty KF, Kњber L, et al. Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF. Diabetes Care. 2021 Feb;44(2):586-94. doi:10.2337/dc20-1675; Gabriel R, Boukichou Abdelkader N, Acosta T, et al. Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data. PLoS One. 2020 Apr;15(4):e0231196. doi:10.1371/journal.pone.0231196; Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019 Jun;5(1):41. doi:10.1038/s41572-019-0092-1; Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res. 2014 Feb;80:21-35. doi:10.1016/j.phrs.2013.12.005; Rahimlou M, Asadi M, Banaei Jahromi N, Mansoori A. Alpha-lipoic acid (ALA) supplementation effect on glycemic and inflammatory biomarkers: A Systematic Review and meta-analysis. Clin Nutr ESPEN. 2019 Aug;32:16-28. doi:10.1016/j.clnesp.2019.03.015; Han T, Bai J, Liu W, Hu Y. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol. 2012 Oct;167(4):465-71. doi:10.1530/EJE-12-0555; Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 year in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011 Sep;34(9):2054-60. doi:10.2337/dc11-0503; Gosselin LE, Chrapowitzky L, Rideout TC. Metabolic effects of α-lipoic acid supplementation in pre-diabetics: a randomized, placebo-controlled pilot study. Food Funct. 2019 Sep;10(9):5732-8. doi:10.1039/c9fo00390h; Haghighatdoost F, Hariri M. Does alpha-lipoic acid affect lipid profile? A meta-analysis and systematic review on randomized controlled trials. Eur J Pharmacol. 2019 Mar;847:1-10. doi:10.1016/j.ejphar.2019.01.001
-
5Academic Journal
Authors: Ляшук, П., Пашковська, Н., Ляшук, Р., Бойко, І., Глуговська, С.
Source: Bukovinian Medical Herald; Vol. 14 No. 3 (55) (2010); 139-144 ; Буковинский медицинский вестник; Том 14 № 3 (55) (2010); 139-144 ; Буковинський медичний вісник; Том 14 № 3 (55) (2010); 139-144 ; 2413-0737 ; 1684-7903
Subject Terms: diabetes mellitus, diabetic neuropathy, pathogenesis, clinical presentation, therapy, сахарный диабет, диабетическая невропатия, патогенез, клиника, лечение, цукровий діабет, діабетична невропатія, клініка, лікування
File Description: application/pdf
Availability: http://e-bmv.bsmu.edu.ua/article/view/247925
-
6Academic Journal
Source: Bukovinian Medical Herald; Vol. 14 No. 3 (55) (2010); 139-144
Буковинский медицинский вестник; Том 14 № 3 (55) (2010); 139-144
Буковинський медичний вісник; Том 14 № 3 (55) (2010); 139-144Subject Terms: сахарный диабет, диабетическая невропатия, патогенез, клиника, лечение, цукровий діабет, діабетична невропатія, клініка, лікування, diabetes mellitus, diabetic neuropathy, pathogenesis, clinical presentation, therapy, 3. Good health
File Description: application/pdf
Access URL: http://e-bmv.bsmu.edu.ua/article/view/247925
-
7Academic Journal
Authors: O. V. Kosivtsova, M. P. Platov, S. A. Kochetov, О. В. Косивцова, М. П. Платов, С. А. Кочетов
Contributors: This article has been supported by Kanonfarma prodakshn. The sponsor has participated in the development of the investigation project and supported the investigation program, as well as in the decision to submit the article for publication., Статья спонсируется компанией ЗАО «Канонфарма продакшн». Спонсор участвовал в разработке проекта исследования и поддержке исследовательской программы, а также принятии решения о представлении статьи для публикации.
Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 12, No 3 (2020); 111-116 ; Неврология, нейропсихиатрия, психосоматика; Vol 12, No 3 (2020); 111-116 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2020-3
Subject Terms: альфа-липоевая (тиоктовая) кислота, neurological complications, diabetic neuropathy, moderate cognitive impairment, dementia, treatment, alpha lipoic (thioctic) acid, неврологические осложнения, диабетическая невропатия, умеренные когнитивные расстройства, деменция, лечение
File Description: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/1374/1067; Mercer SW, Smith SM, Wyke S, et al. Multimorbidity in primary care: developing the research agenda. Fam Pract. 2009 Apr;26(2): 79-80. doi:10.1093/fampra/cmp020.; Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012 Jul 7;380(9836):37-43. doi:10.1016/S0140-6736(12)60240-2. Epub 2012 May 10.; Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc. 2012 Oct;60(10):E1-E25. doi:10.1111/j.1532-5415.2012.04188.x. Epub 2012 Sep 19.; Dunlay SM, Givertz MM, Aguilar D, et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019 Aug 13;140(7):e294-e324. doi:10.1161/CIR.0000000000000691. Epub 2019 Jun 6.; Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047-53. doi:10.2337/diacare.27.5.1047.; Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Aug 22;386(9995):743-800. doi:10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.; Furuta A, Ishii N, Nishihara Y, Horie A. Medullary arteries in aging and dementia. Stroke. 1991 Apr;22(4):442-6. doi:10.1161/01.str.22.4.442.; Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009 Apr 15;301(15):1565-72. doi:10.1001/jama.2009.460.; Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017 Dec 16;390(10113):2673-2734. doi:10.1016/S0140-6736(17)31363-6. Epub 2017 Jul 20.; Chatterjee S, Peters SA, Woodward M, Mejia AS, Batty GD, Beckett N, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016 Feb; 39(2):300-7. doi:10.2337/dc15-1588. Epub 2015 Dec 17.; Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018 Oct;14(10):591-604. doi:10.1038/s41574-018-0048-7.; Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011 Jul;91(3):795-826. doi:10.1152/phys-rev.00042.2009.; Lindsay ZA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and Cognitive Impairment. Curr Diab Rep. 2016 Sep;16(9):87. doi:10.1007/s11892-016-0775-x.; Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011 Nov;10(11):969-77. doi:10.1016/S1474-4422(11)70188-0. Epub 2011 Sep 28.; Erus G, Battapady H, Zhang T, et al. Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose. Diabetes Care. 2015 Jan;38(1):97-104. doi:10.2337/dc14-1196. Epub 2014 Oct 21.; Boulton AJM. Diabetic neuropathy and foot complications. Handb Clin Neurol. 2014;126: 97-107. doi:10.1016/B978-0-444-53480-4.00008-4.; Lobmann R. Diabetic foot syndrome. Internist (Berl). 2011 May;52(5):539-48. doi:10.1007/s00108-010-2733-z.; Volmer-Thole M, Lobmann R. Neuropathy and Diabetic Foot Syndrome. Int J Mol Sci. 2016 Jun 10;17(6):917. doi:10.3390/ijms17060917.; Malik RA, Tesfaye S, Newrick PG, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia. 2005 Mar;48(3):578-85. doi:10.1007/s00125-004-1663-5. Epub 2005 Feb 24.; Pfutzner A, Forst T, Engelbach M, et al. The influence of isolated small nerve fibre dysfunction on microvascular control in patients with diabetes mellitus. Diabet Med. 2001 Jun; 18(6):489-94. doi:10.1046/j.1464-5491.2001.00524.x.; Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001 Nov;44(11):1973-88. doi:10.1007/s001250100001.; Brown MR, Dyck PJ, McClearn GE, et al. Central and peripheral nervous system complications. 1982;31(Suppl 1 Pt 2):65-70. doi:10.2337/diab.31.1.s65.; Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment. Muscle Nerve. 2002 Apr;25(4):477-91. doi:10.1002/mus.10080.; Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-154. doi:10.2337/dc16-2042.; Martin CL, Albers JW, Pop-Busui R; DCCT/EDIC Research Group. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care.2014;37(1):31-8. doi:10.2337/dc13-2114.; Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002 Jan 12;324(7329):71-86. doi:10.1136/bmj.324.7329.71.; Capodanno D, Angiolillo DJ. Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus. Circulation. 2016 Nov 15;134(20):1579-1594. doi:10.1161/CIRCULATIONAHA.116.023164. Epub 2016 Oct 11.; American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S111-S134. doi:10.2337/dc20-S010.; Boer IH, Bakris G, Cannon CP. Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations. JAMA. 2018 Apr 3;319(13): 1319-1320. doi:10.1001/jama.2018.0642.; Громова ОА, Торшин ИЮ, Калачева АГ и др. Тройственный синергизм этилметил-гидроксипиридина сукцината, магния и витамина В6: молекулярные механизмы. Неврология, нейропсихиатрия, психосоматика. 2017;9(1):42-9. doi:10.14412/2074-27112017-1-42-49; Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006 Nov;29(11): 2365-70. doi:10.2337/dc06-1216.; Строков ИА, Ахметжанова ЛТ, Солоха ОА. Эффективность лечения диабетической полиневропатии таблетированной формой альфа-липоевой кислоты. Трудный пациент. 2010;8(3):13-8.; Ruhnau KJ, Meissner HP, Finn JR, et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med. 1999 Dec;16(12):1040-3. doi:10.1046/j.1464-5491.1999.00190.x.; Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003 Mar;26(3): 770-6. doi:10.2337/diacare.26.3.770.; Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004 Feb;21(2): 114-21. doi:10.1111/j.1464-5491.2004.01109.x.; Строков ИА, Захаров ВВ, Строков КИ. Диабетическая энцефалопатия. Неврология, нейропсихиатрия, психосоматика. 2012;4(2S):30-40. doi:10.14412/2074-27112012-2506; Старчина ЮА, Захаров ВВ. Неврологические осложнения сахарного диабета. Эффективная фармакотерапия. 2019;15(19):30-7.
-
8Academic Journal
Authors: Maria А. Cherdak, E. А. Mkhitaryan, М. А. Чердак, Э. А. Мхитарян
Source: Meditsinskiy sovet = Medical Council; № 11 (2020); 53-62 ; Медицинский Совет; № 11 (2020); 53-62 ; 2658-5790 ; 2079-701X
Subject Terms: альфа-липоевая кислота, diabetic neuropathy, elderly, neuropathic pain, autonomic neuropathy, lipoic acid, диабетическая невропатия, пожилые, невропатическая боль, вегетативная невропатия
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/5753/5251; Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th ed. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843.; Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А., Дедов И.И. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие? Терапевтический архив. 2019;91(10):4–13. doi:10.26442/00403660.2019.10.000364.; Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104–112. doi:10.14341/DM2004116-17.; Corriere M., Rooparinesingh N., Kalyani R.R. Epidemiology of diabetes and diabetes complications in the elderly: an emerging public health burden. Curr Diab Rep. 2013;13(6):805–813. doi:10.1007/s11892-013-0425-5.; Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., Byrd-Holt D.D., Li C. et al. Full accounting of diabetes and pre-diabetes in the U. S. population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287–294. doi:10.2337/dc08-1296.; Brown A.F., Mangione C.M., Saliba D., Sarkisian C.A. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(Suppl Guidelines):S265–S280. doi:10.1046/j.1532-5415.51.5s.1.x.; Juster-Switlyk K., Smith A.G. Updates in diabetic peripheral neuropathy. F1000Res. 2016;5:F1000FacultyRev-738. doi:10.12688/f1000research.7898.1.; Verrotti A., Prezioso G., Scattoni R., Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne). 2014;5:205. doi:10.3389/fendo.2014.00205.; Hicks C.W., Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep. 2019;19(10):86. doi:10.1007/s11892-019-1212-8.; Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017;20(1):13–41. doi:10.14341/DM8664.; Vinik A.I., Strotmeyer E.S., Nakave A.A., Patel C.V. Diabetic neuropathy in older adults. Clin Geriatr Med. 2008;24(3):407‐v. doi:10.1016/j.cger.2008.03.011.; Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kempler P. et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments [published correction appears in Diabetes Care. 2010 Dec;33(12):2725]. Diabetes Care. 2010;33(10):2285–2293. doi:10.2337/dc10-1303.; Dimitropoulos G., Tahrani A.A., Stevens M.J. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5(1):17–39. doi:10.4239/wjd.v5.i1.17.; Баринов А.Н., Новосадова М.В. Вегетативная невропатия при сахарном диабете: клинические проявления, диагностика и лечение. Неврология, нейропсихиатрия, психосоматика. 2011;3(2):25–33. doi:10.14412/2074-2711-2011-143.; Sabanayagam C., Liew G., Tai E.S., Shankar A., Lim S.C. Subramaniam T. et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia. 2009;52(7):1279–1289. doi:10.1007/s00125-009-1360-5.; Popescu S., Timar B., Baderca F., Simu M., Diaconu L., Velea I., Timar R. Age as an independent factor for the development of neuropathy in diabetic patients. Clin Interv Aging. 2016;11:313–318. doi:10.2147/CIA.S97295.; Qu G.B., Wang L.L., Tang X., Wu W., Sun Y.-H. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: An update systematic review and meta-analysis. J Clin Transl Endocrinol. 2017;9:25–31. doi:10.1016/j.jcte.2017.04.001.; Rosenberger D.C., Blechschmidt V., Timmerman H., Wolff A., Treede R.-D. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm. 2020;127:589–624. doi:10.1007/s00702-020-02145-7.; Dyck P.J., Albers J.W., Andersen H., Arezzo J.C., Biessels G.-J., Bril V. et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27(7):620–628. doi:10.1002/dmrr.1226.; Grewal A.S., Bhardwaj S., Pandita D., Lather V., Sekhon B.S. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases. Mini Rev Med Chem. 2016;16(2):120–162. doi:10.2174/1389557515666150909143737.; Lappas M., Permezel M., Rice G.E. Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappa B and extracellular signal-regulated kinase 1/2. J Endocrinol. 2007;193(2):269–277. doi:10.1677/JOE-06-0081.; Bachewal P., Gundu C., Yerra V.G., Kalvala A.K., Areti A., Kumar A. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. Biofactors. 2018;44(2):109–122. doi:10.1002/biof.1397.; Tóbon-Velasco J.C., Cuevas E., Torres-Ramos M.A. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014;13(9):1615–1626. doi:10.2174/1871527313666140806144831.; Oates P.J. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol. 2002;50:325–392. doi:10.1016/s0074-7742(02)50082-9.; Singleton J.R., Smith A.G., Russell J.W., Feldman E.L. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52(12):2867–2873. doi:10.2337/diabetes.52.12.2867.; Boulton A.J., Malik R.A. Neuropathy of impaired glucose tolerance and its measurement. Diabetes Care. 2010;33(1):207–209. doi:10.2337/dc09-1728.; Papanas N., Ziegler D. Prediabetic neuropathy: does it exist? Curr Diab Rep. 2012;12(4):376–383. doi:10.1007/s11892-012-0278-3.; Thrainsdottir S., Malik R.A., Dahlin L.B., Wiksell P., Eriksson K.F., Rosén I. et al. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes. 2003;52(10):2615–2622. doi:10.2337/diabetes.52.10.2615.; Malik R.A., Tesfaye S., Newrick P.G., Walker D., Rajbhandari S.M., Siddique I. et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia. 2005;48(3):578–585. doi:10.1007/s00125-004-1663-5.; Yagihashi S., Mizukami H., Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig. 2011;2(1):18–32. doi:10.1111/j.2040-1124.2010.00070.x.; Lozeron P., Nahum L., Lacroix C., Ropert A., Guglielmi J.-M., Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 2002;249(5):569–575. doi:10.1007/s004150200066.; Строков И.А., Фокина А.С., Ахмеджанова Л.Т., Баринов А.Н. Модернизация представлений о диабетической полиневропатии в период 2010–2018 гг. Трудный пациент. 2018;12(16):16–20. doi:10.24411/2074-1995-2018-10038.; Spallone V., Morganti R., D’Amato C., Greco C., Cacciotti L., Marfia G.A. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012;29(5):578–585. doi:10.1111/j.1464-5491.2011.03500.x.; Achterberg W.P., Pieper M.J., van Dalen-Kok A.H., de Waal M.W., Husebo B.S., Lautenbacher S. et al. Pain management in patients with dementia. Clin Interv Aging. 2013;8:1471–1482. doi:10.2147/CIA.S36739.; Pickering G., Marcoux M., Chapiro S., David L., Rat P., Michel M. et al. An Algorithm for Neuropathic Pain Management in Older People. Drugs Aging. 2016;33(8):575–583. doi:10.1007/s40266-016-0389-7.; Violan C., Foguet-Boreu Q., Flores-Mateo G., Salisbury C., Blom J., Freitag M. et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7):e102149. doi:10.1371/journal.pone.0102149.; Hein C., Forgues A., Piau A., Sommet A., Vellas B., Nourhashémi F. Impact of polypharmacy on occurrence of delirium in elderly emergency patients. J Am Med Dir Assoc. 2014;15(11):850.e11-850.e8.5E15. doi:10.1016/j.jamda.2014.08.012.; Kaku M., Vinik A., Simpson D.M. Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep. 2015;15(6):609. doi:10.1007/s11892-015-0609-2.; Martin C.L., Albers J., Herman W.H., Cleary P., Waberski B., Greene D.A. et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006;29(2):340–344. doi:10.2337/diacare.29.02.06.dc05-1549.; Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–117. doi:10.1016/0168-8227(95)01064-k.; Azad N., Emanuele N.V., Abraira C., Henderson W.G., Colwell J., Levin S.R. et al. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999;13(5–6):307–313. doi:10.1016/s1056-8727(99)00062-8.; Calles-Escandón J., Lovato L.C., Simons-Morton D.G., Kendall D.M., PopBusui R., Cohen R.M. et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010;33(4):721–727. doi:10.2337/dc09-1471.; Chaturvedi N. Metabolic memory in the autonomic neuropathy of diabetes: implications for pathogenesis and patient care. Circulation. 2009;119(22):2865–2867. doi:10.1161/CIRCULATIONAHA.109.867036.; Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R. et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962. doi:10.2337/diacare.28.4.956.; Lin J., Bierhaus A., Bugert P., Dietrich N., Feng Y., vom Hagen F. et al. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia. 2006;49(5):1089–1096. doi:10.1007/s00125-006-0174-y.; Yi X., Maeda N. alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/lowcholesterol diet. Diabetes. 2006;55(8):2238–2244. doi:10.2337/db06-0251.; Du X., Edelstein D., Brownlee M. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia. 2008;51(10):1930–1932. doi:10.1007/s00125-008-1100-2.; Храмилин В.Н., Демидова И.Ю., Игнатова О.Ю. Оценка эффективности различных режимов пероральной терапии альфа-липоевой кислотой болевой формы диабетической периферической полинейропатии. Сахарный диабет. 2010;(2):28–32. doi:10.14341/2072-0351-5670.; Mijnhout G.S., Kollen B.J., Alkhalaf A., Kleefstra N., Bilo H.J.G. Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. Int J Endocrinol. 2012;2012:456279. doi:10.1155/2012/456279.; Lee W.Y., Orestes P., Latham J., Naik A.K., Nelson M.T., Vitko I. et al. Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J Neurosci. 2009;29(30):9500–9509. doi:10.1523/JNEUROSCI.5803-08.2009.; Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997;20(3):369–373. doi:10.2337/diacare.20.3.369.; Serhiyenko V., Serhiyenko L., Serhiyenko A. Alpha-lipoic acid and diabetic cardiac autonomic neuropathy. MOJ Public Health. 2019;8(1):8‒10. Available at: https://medcraveonline.com/MOJPH/MOJPH-08-00276.pdf.; Ziegler D., Low P.A., Litchy W.J., Boulton A.J.M, Vinik A.I., Freeman R. et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34(9):2054–2060. doi:10.2337/dc11-0503.; Attal N., Cruccu G., Baron R., Haanpää M., Hansson P., Jensen T.S., Nurmikko T. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88. doi:10.1111/j.1468-1331.2010.02999.x.; Bril V., England J.D., Franklin G.M., Backonja M., Cohen J.A., Del Toro D.R. et al. Evidence-based guideline: treatment of painful diabetic neuropathy– report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. Muscle Nerve. 2011;43(6):910–917. doi:10.1002/mus.22092.; Çakici N., Fakkel T.M., van Neck J.W., Verhagen A.P., Coert J.H. Systematic review of treatments for diabetic peripheral neuropathy. Diabet Med. 2016;33(11):1466–1476. doi:10.1111/dme.13083.; Gibson W., Wand B.M., O’Connell N.E. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;9(9):CD011976. doi:10.1002/14651858.CD011976.pub2.
-
9Academic Journal
Authors: EA Katushkina, OE Zinovyeva
Source: Медицинский совет, Vol 0, Iss 7, Pp 43-47 (2014)
Subject Terms: сахарный диабет, диабетическая невропатия, невропатическая боль, diabetes mellitus, diabetic neuropathy, neuropathic pain, Medicine
File Description: electronic resource
-
10
-
11Academic Journal
Authors: Пилипович, Анна
Subject Terms: САХАРНЫЙ ДИАБЕТ,ДИАБЕТИЧЕСКАЯ НЕВРОПАТИЯ,НЕЙРОМЕТАБОЛИЧЕСКИЕ ПРЕПАРАТЫ,ТИОКТОВАЯ КИСЛОТА
File Description: text/html
-
12Academic Journal
Authors: Zorii, I. A., Pashkovska, N. V.
Source: Clinical and experimental pathology; Vol. 12 No. 1 (2013) ; Клиническая и экспериментальная патология; Том 12 № 1 (2013) ; Клінічна та експериментальна патологія; Том 12 № 1 (2013) ; 2521-1153 ; 1727-4338
Subject Terms: Type 2 diabetes, diabetic neuropathy, electromyography indicators, glycosylated hemoglobin, Сахарный диабет 2 типа, диабетическая невропатия, показатели электромиографии, гликозилированный гемоглобин, Діабет 2 типу, діабетична нейропатія, показники електроміографії, глікозильований гемоглобін
File Description: application/pdf
-
13Academic Journal
Source: Bulletin of Siberian Medicine; Том 12, № 1 (2013); 101-108 ; Бюллетень сибирской медицины; Том 12, № 1 (2013); 101-108 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2013-12-1
Subject Terms: diabetic neuropathy, diabetes, diagnosis, axonopathy, demyelinating, retinal сonfocal microscopy, optical coherent tomography, диабетическая невропатия, сахарный диабет, диагностика, аксонопатия, де-миелинизация, ретинальная конфокальная микроскопия, оптическая когерентная томография
File Description: application/pdf
Relation: https://bulletin.tomsk.ru/jour/article/view/46/47; Аметов А.С. Сахарный диабет. Проблемы и решения. М.: ГЭОТАР-Медиа, 2011. 680 с.; Баранцевич Е.Р. Посохина О.В. Подходы к терапии неврологических проявлений сахарного диабета // Журн. неврологии и психиатрии. 2010. № 4. С. 63–66.; Браун М.Ж., Грин Д.А. Диабетическая невропатия: патофизиология и лечение // Заболевания периферической нервной системы / под ред. А.К Эсберн, Р.У. Джиллиата. М., 1987. С. 163–194.; Галстян Г.Р. Диабетическая нейропатия: особенности клинического течения, современные возможности терапии // Эффективная фармакотерапия в эндокринологии. 2009. № 4. С. 20–26.; Гехт Б.М. Теоретическая и клиническая электромиография. 1990. С. 240–250.; Дедов И.И. Новые возможности терапии сахарного диабета 2 типа // Сахарный диабет. 2009. Спец. выпуск. С. 1–3.; Котов С.В., Калинин А.П., Рудакова И.Г. Диабетическая нейропатия. М.: МИА, 2011. С. 56–79.; Свирин А.В., Кийко Ю.И., Обруч Б.В., Богомолов А.В. Спектральная оптическая когерентная томография: принципы и возможности метода. URL: http://www.far-manotes.ru/spektralnaya- opticheskaya- kogerentnaya- tomo-grafiya-principy-i-vozmozhnosti-metoda (дата обращения: 04.12.11).; Строков И.А., Аметов А.С., Козлова Н.А., Галеев И.В. Клиника диабетической невропатии // Рус. мед. журн. 1998. Т. 6, № 12. C. 797–801.; Строков И.А., Новосадова М.В., Баринов А.Н., Яхно Н.Н. Клинические методы оценки диабетической полинейропатии // Неврол. журн. 2000. № 5. С. 14–18.; Celicer R., Basgoze O., Bayraktar M. Early detection of neurological involvement in diabetes mellitus // Electromyogr. Clin. Neurophysiol. 1996. V. 36. P. 29–35.; Dipika V Patel., Charles Nj McGhee. Contemporary in vivo confocal microscopy of the living human cornea using white light and laser scanning techniques:major review // Clinical and Experimental Opthalmology. 2007. V. 35. P. 71–88.; DCCT Reserch Group: The effect of intensive diabetes treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus // N. Engl. J. Med. 1993. V. 329. P. 997–1005.; DCCT Reserch Group. Factors in development of diabetes therapy on the development and progression of neuropathy // Diabetes. 1998. V. 37. P. 476–483.; Dyck P.J. Detection, characterization, and staging of poly-neuropathy: assessed in diabetics // Muscle and Nerve. 1998. V. 11. P. 21–32.; Dyck P.J., Albers J.W., Andersen H., Arezzo J.C., Biessels G.J. Diabetic Polyneuropathies: Update on Research Definition, Diagnostic Criteria and Estimation of Severity // Diabetes Metab. Res. Rev. 2011. P. 2456–2466.; Efron N. The Glenn A. Fry award lecture 2010: Ophthalmic markers of diabetic neuropathy // Optom. Vis. Sci. 2011. V. 88(6). P. 661–683.; Ites K.I., Anderson E.J., Cahill M.L., Kearney J.A., Post E.C., Gilchrist L.S. Balance interventions for diabetic peripheral neuropathy: a systematic review // J. Geriatr. Phys. Ther. 2011. Jul.–Sep. 34(3). P. 109–116.; Feldman E.L. A practical two step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy // Diabetes Care. 1994. V. 17, № 11. P. 1281–1289.; Gomes A.A., Onodera A.N., Otuzi M.E., Pripas D., Mezzarane R.A., Sacco I.C. Electromyography and kinematic changes of gait cycle at different cadences in diabetic neu-ropathic individuals // Muscle Nerve. 2011. Aug. 44(2). P. 258–268.; Grant J.A., O’Brien P., Dyck P.J. Neuropathy test and normative results // Diabetic Neuropathy. Philadelphia, 1999. P. 123–134.; Harris M., Eastman R., Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population // Dia-betes Care. 1993. V.16. P. 1446–1450.; King R.H. The role of glycation in the pathogebesis of diabetic polineuropathy // Mol. Pathol. 2001. № 54. P. 400–408.; Leeds J.S., Hopper A.D., Hadjivassiliou M., Tesfaye S., Sanders D.S. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease // Diabetes Care. 2011. Oct. 34(10). P.2158–2163.; Magri C.J., Calleja N., Buhagiar G., Fava S., Vassallo J. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy // Postgrad. Med. J. 2011. Oct. 87(1032). P. 658–63.; Maser R.E., Laudadio C., De Cherney G.S. The effects of age and diabetes mellituson nerve function // J. Am. Geriatr. Soc. 1993. V. 41 (11). P. 1202.; Mastropasqua L., Nubile M. Confocal Microscopy of the Cornea // SLACK Incorporated. USA. 2002. P. 122.; Nowicki M., Kosacka J., Serke H., Blüher M., Spanel-Borowski K. Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesi-ty, peripheral diabetic polyneuropathy, and the metabolic syndrome // J. Neurosci. Res. 2011. P. 1226.; Oliveira-Soto L., Efron N. Morphology of corneal nerves us-ing confocal microscopy // Cornea. 2001. V. 20, no. 4. P. 374–384.; Patel S., McLaren J., Hodge D. et al. Normal human keratocyte density and corneal thickness measurement by us-ing confocal microscopy in vivo // Invest. ophthalmol.Vis. Sci. 2001. V. 42. № 2. Р. 333–339.; Periquet M.I., Novak V., Collins M.P. et al. Paiful sensory neuropathy. Prospective evalution using skin biopsy // Neurology. 1999. P. 1641–1647.; Podwall D., Gooch C. Diabetic neuropathy: Сlinical features, etiology, and therapy // Curr. Neurol. Neurosci. Rep. 2004. Jan. 4(1). P. 55–61.; Quatrini C., Tavakoli M., Jeziorska. M, Kallinikos P., Tesfaye S., Finigan J. et al. Surrogate markers of small fiber damage in human diabetic neuropathy // Diabetes. 2007. P. 2148–2154.; Rendell M.S., Katims J.J., Richter R., Rowland F.A. A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy // J. Neurol. Neurosurg. Psychiatr. 1989. V. 52. P. 502–511.; Somodi S., Hahnel C., Slowic C. et al. Confocal in vivo microscopy and confocal laser–scanning fluorescence micros-copy in keratoconus // Ger. J. Ophthalmol. 1996. V. 5, no. 6. Р. 518–525.; Sohn M.W., Whittle J., Pezzin L.E., Miao H., Dillingham T.R. Electrodiagnostic consultation and identification of neu-romuscular conditions in persons with diabetes // Muscle Nerve. 2011. 43(6). Р. 812–817.; Sugimoto K., Murakawa Y., Sima A.A. Diabetic neuropathy-continuing enigma // Diabetes Metab. Res. Rev. 2000. 16. P. 408–433.; Tavakoli M., Marshal A., Thompson L., Efron N., Malik R. Corneal confocal microscopy: A novel noninvasive means to diagnose neuropathy in patients with fabry disease // Muscle and Nerve. 2009. P. 976–984.; Tavakoli M., Marshal A., Thompson L., Efron N., Malik R. Corneal confocal microscopy is reduced and relates to the severity of neuropathy in patients with diabetes // Diabetes care. 30. 2007. P. 1895–1897.; Tavakoli M., Asghar O., Alam U. et al. Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy // Therapeutic Advances in Endocrinology and Metabolism. 2010. P. 69–88.; Thomas P.K. Classifications, differential diagnosis, and stag-ing of diabetic peripheral neuropathy // Diabetes. 1997. V. 46. P. 54–57.; Thomas P.K. Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factor for development of interventions // Eur. Neurol. 1999. V. 41. P. 35–43.; Varano M., Scassa C., Ripandelli G. et al. New diagnostic tools for macular edema // Doc Opthalmol. 1999. V. 97. P. 373–379.; Wang W., Balamurugan A., Biddle J., Rollins K.M. Diabetic neuropathy status and the concerns in underserved rural communities: challenges and opportunities for diabetes edu-cators // Diabetes Educ. 2011. P. 536–548.; Wygledowska-Promienska D., Rokita-Wala I., Gierek-Ciaciura S. et al. The alterations in the corneal structure at III/IV stage of keratoconus by means of confocal microscopy and ultrasound biomicroscopy before penetrating keratoplasty // Klin. Oczna. 1999. V. 101, no. 6. Р. 427–432.; Yoshida A. New examination methods for macular disorders-application of diagnosis and treatment // Nippon Ganka Zasshi. 2000. V.104. P.899–942.; Ziegler D. The design of clinical trials for treatment of diabetic neuropathy // Neuroscience Research Communications. 1997. V. 21. P. 83–91; Ziegler D., Gries F.A. Nervenheilkunhe. 1993. P. 405–410.; https://bulletin.tomsk.ru/jour/article/view/46
-
14Academic Journal
Authors: Цыренжапова, Р., Алифирова, В.
Subject Terms: ДИАБЕТИЧЕСКАЯ НЕВРОПАТИЯ, САХАРНЫЙ ДИАБЕТ, ДИАГНОСТИКА, АКСОНОПАТИЯ, ДЕМИЕЛИНИЗАЦИЯ, РЕТИНАЛЬНАЯ КОНФОКАЛЬНАЯ МИКРОСКОПИЯ, ОПТИЧЕСКАЯ КОГЕРЕНТНАЯ ТОМОГРАФИЯ, RETINAL СONFOCAL MICROSCOPY
File Description: text/html
-
15Academic Journal
Authors: Ye. Korolyova S., R. Tsyrenzhapova B., V. Alifirova M., N. Novikova S., Е. Королёва С., Р. Цыренжапова Б., В. Алифирова М., Н. Новикова С.
Source: Bulletin of Siberian Medicine; Том 11, № 3 (2012); 43-47 ; Бюллетень сибирской медицины; Том 11, № 3 (2012); 43-47 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2012-11-3
Subject Terms: diabetic neuropathy, paraneoplastic polyneuropathy, axonopathy, demyelinating, onconeural antigens, диабетическая невропатия, паранеопластическая полиневропатия, аксонопатия, демиелинизация, онконевральные антигены
File Description: application/pdf
Relation: https://bulletin.tomsk.ru/jour/article/view/477/466; Гланц С. Медико-биологическая статистика. М.: Практика, 1998. 459 с.; Левин О.С. Полинейропатии: клиническое руководство. Мед. информ. агентство, 2005. 495 с.; Леонов В.П. Как описывать статистику в медицине. Руководство для авторов, редакторов и рецензентов. М.: Практич. медицина, 2011. 488 с.; Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М.: Медиа Сфера, 2004. 352 с.; Bruyn R.P.M. Paraneoplastic polyneuropathy // Handbook of Clinical Neurology. 1987. № 7. P. 465—473.; Buckanovich R.J., Yang Y.Y.L., Darnell R.B. The Onconeu-ral Antigen Nova-l Is a Neuron-SpecificRNA-Binding Protein, the Activity of which Is Inhibited by Paraneoplastic Antibodies // J. of Neuroscience. February 1. 1996. V. 16, № 3. P. 1114—1122.; Kempler P. Neuropathies. Pathomechanism, clinical presen-tation, diagnosis, therapy / Ed. by P. Kemple. Springer, 2002. 208 p.; Musunuru K., Darnell R.B. Paraneoplastic neurologic dise-ase. Antigens: RNA-Binding Proteins and Signaling Proteins in Neuronal Degeneration // Annu. Rev. Neurosci. 2001. № 24. P. 239—262.; Molina-Garrido M.J., Guillen-Ponce C., Martinez S., Guirado-Risuefio M. Diagnosis and current treatment of neurological paraneoplastic syndromes // Transl. Oncol. 2006. V. 8, № 11. P. 796—801.; Stevens M.J., Latimer S.A., Kamijo M. et al. Osmotically- nerve taurine depletion and complatible asmolyte hypothesis in experimental diabetic neuropathy in the rat // Diabetologia. 1993. № 36. P. 608—614.; https://bulletin.tomsk.ru/jour/article/view/477
-
16Academic Journal
Authors: Перцева, Н., Данилова, А., Пастарус, Л.
Subject Terms: ДИАБЕТИЧЕСКАЯ НЕВРОПАТИЯ, ЛЕЧЕНИЕ, АКТОВЕГИН, НЕЙРОБИОН, КЕЛТИКАН, ДіАБЕТИЧНА НЕВРОПАТіЯ, ЛіКУВАННЯ, АКТОВЕГіН, НЕЙРОБіОН
File Description: text/html
-
17Academic Journal
Authors: Королёва, Екатерина, Цыренжапова, Р., Алифирова, В., Новикова, Н.
Subject Terms: ДИАБЕТИЧЕСКАЯ НЕВРОПАТИЯ, ПАРАНЕОПЛАСТИЧЕСКАЯ ПОЛИНЕВРОПАТИЯ, АКСОНОПАТИЯ, ДЕМИЕЛИНИЗАЦИЯ, ОНКОНЕВРАЛЬНЫЕ АНТИГЕНЫ
File Description: text/html
-
18Academic Journal
Authors: Е. А. Широков, А. А. Михайлов
Source: The Russian Archives of Internal Medicine; № 1 (2011); 48-54 ; Архивъ внутренней медицины; № 1 (2011); 48-54 ; 2411-6564 ; 2226-6704 ; 10.20514/2226-6704-2011-0-1
Subject Terms: Тригамма®, pyridoxine, cyanоcobalamine, nervous system diseases, neuritis, diabetic neuropathy, neuroprotectors, Trigamma®, пиридоксин, цианокобаламин, заболевания нервной системы, невриты, диабетическая невропатия, нейропротекторы
File Description: application/pdf
Relation: https://www.medarhive.ru/jour/article/view/13/12; Белоусов Ю.Б. Клиническая фармакология и фармакотерапия. 3-е изд., испр. и доп. М.: ООО «Медицинское информационное агентство», 2010. 872 с.; Воробьев С., Кириченко Д., Паленый А. Препараты «тиогамма» и «мильгамма» в терапии гастроинтестинальной формы автономной нейропатии при сахарном диабете типа 2 // Врач. 2007. № 11. С. 27– 30.; Дамулин И.В. Терапевтические возможности применения препарата тригамма в неврологической практике // Вестник невропатологии, психиатрии и нейрохирургии. 2011. № 7. С. 21–29.; Дамулин И.В., Шмидт Т.Е. Неврологические расстройства при алкоголизме // Неврологический журнал. 2004. № 2. С. 4–10.; Данилов А.Б. Витамины группы В в лечении болевых синдромов // Трудный пациент. 2010. № 12. С. 1–8.; Данилов А.Б. Витамины группы В в лечении острых болей в спине: миф или реальность? // Лечащий врач. 2007. № 4. С. 1–8.; Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: Боргес, 2007. 191 с.; Кукес В., Ших Е., Махова А. Клинико-фармакологические преимущества бенфотиамина при лечении полинейропатии // Врач. 2009. № 4. С. 43–46.; Луцкий И.С., Лютикова Л.В., Луцкий Е.И. Витамины группы В в неврологической практике // Междунарный неврологический журнал. 2008. № 5. С. 89–93.; Строков И.А., Ахмеджанова Л.Т., Солоха О.А. Витамины группы В в лечении неврологических заболеваний // Российский медицинский журнал. Неврология. Психиатрия. 2009. Т. 17. № 11.; Строков И.А., Строков К.И., Афонина Ж.А. Патогенетическая терапия диабетической полиневропатии // Лечащий врач. 2009. № 13. С. 10–64.; Супонева Н., Павлов Э. Диагностика и базовая терапия хронический полиневропатий // Врач. 2009. № 9. С. 43–44.; Энциклопедический словарь медицинских терминов. М.: Советская энциклопедия, 1982. Т. 1. С. 210.; Allen L.H. How common is vitamin B12 deficiency // Am. J. Clin. Nutr. 2009. Vol. 89. № 2. P. 6935–6965.; Brownlee M. Biochemistry and molecular cell biology of diabetic complication // Nature. 2001. Vol. 414. P. 813–820.; Brownlee M. The pathobiology of diabetic complications: a unifying mechanism // Diabetes. 2005. Vol. 54. Р. 1615–1625.; Caram-Salas N.L., Reyes-Garcia G., Medina-Santillian R. et al. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone // Pharmacology. 2006. Vol. 77. № 2. P. 53–62.; Eckert M., Schejbal P. Therapy of neuropathies with a vitamin B combination. Symptomatic treatment of painful diseases of the peripheral nervous system with a combination preparation of thiamine, pyridoxine and cyanocobalamin // Fortschr. Med. 1992. Vol. 110. № 29. P. 544–548.; El Otmani H., Moutaouakil F., Midafi N. et al. Cobalamin deficiency: neurological aspects in 27 cases // Rav. Neurol. (Paris). 2009. Vol. 165. № 3. P. 263–267.; Erickson K.I., Suever B.L., Prakash R.S. et al. Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study // Brain Res. 2008. Vol. 1199. P. 20–26.; Eussen S.J., de Groot L.C., Joosten L.W. et al. Effect of oral vitamin B12 with or without folic acid on cognitive function in older people with mild vitamin B12 deficiency: a randomized, placebo–controlled trial // Am. J. Clin. Nutr. 2006. Vol. 84. № 2. P. 361–370.; Fisher M., Lees K. Nutrition and stroke prevention // Stroke. 2006. Vol. 37. P. 2430–2435.; Gibson A., Woodside J.V., Young I.S. et al. Alcohol increases homocysteine and reduces B vitamin concentration in healthy male volunteers — a randomized, crossover intervention study // OJM. 2008. Vol. 101. № 11. P. 881–887.; Hodis H.N., Mack W.J., Dustin L. et al. High-dose B vitamin supplementation and progression of subclinical atherosclerosis: randomized controlled trial // Stroke. Vol. 40. № 3. P. 730–736.; Jurna I. Analgetic and analgesia-potentiating action of B vitamins // Schmerz. 1998. Vol. 12. № 2. P. 136–141.; Kobzar G., Mardia V., Ratsep I. et al. Effect of vitamin B6 vitamers on platelet aggregation // Platelets. 2009. Vol. 20. P. 120–124.; Kuwahara H., Noguchi Y., Inaba A. et al. Case of an 81-year-old women with theophylline-associated sezures followed by partial seizures due to vitamin B6 deficiency // Rinsho Shinkeigaku. 2008. Vol. 48. № 2. P. 125–129.; Lemoine A., Le Devehat C. Clinical conditions requiring elevated dosages of vitamins // Int. J. Vitam. Nutr. Res. Suppl. 1989. Vol. 30. P. 129–147.; Lin J., Lin K., Masruha M.R. et al. Pyridoxine-dependant epilepsy initially responsive to phenobarbital // Arq. Neuro-Psyquiatr. 2007. Vol. 65. P. 1026–1029.; Major P., Greenberg E., Khan A. et al. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results // Epilepsy Behav. 2008. Vol. 13. P. 557–559.; Mehta R., Shangari N., O’Braen P.J. Preventing cell death induced by carbonil stress, oxidative stress or mitochondrial toxins with vitamin B anti-AGE agents // Mol. Nutr. Food Res. 2008. Vol. 52. P. 379–385.; Mooney S., Leuendorf J.E., Hendrickson C. et al. Vitamin B6: a long known compound of surprising complexity // Molecules. 2009. Vol. 14. P. 329–351.; Nardin R.A., Amic A.N., Raynor E.M. Vitamin B12 and methylmalonic acid levels in patients presenting with polyneuropathy // Muscle Nerve. 2007. Vol. 36. P. 532–535.; O’Connor D., Marshall S., Massy-Westropp N. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome // Cochrane Database Syst. Rev. 2003. Vol. 1. CD003219.; Peters T.J., Kotowicz J., Nyka W. et al. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomized controlled trial // Alcohol and Alcoholism. 2006. Vol. 41. P. 636–642.; Ryle P.R., Thompson A.D. Nutrition and vitamins in alcoholism // Contemp. Issues Clinic Biochem. 1984. P. 188–224.; Schmidt J. Wirksamkeit von benfotiamin bei diabetischer neuropathie — breite anwendungsbeobachtung unterstreicht praxisbenefit // Der KaSSENARZT, Helt. 2002. Vol. 14–15. P. 40–43.; Spooner G.R., Desai H.B., Angel J.F. et al. Using piridoxone to treat carpal tunnel syndrome. Randomized controlled trial // Can. Fam. Physician. 1993. Vol. 39. P. 2122–2127.; Sun Y., Lai M.S., Lu C.J. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials // Acta Neurol. Taiwan. 2005. Vol. 14. P. 48–54.; Van Dam F., Van Gool W.A. Hyperhomocysteinemia and Alzheimer’s disease: a systematic review // Arch. Gerontol. Geriatr. 2009. Vol. 48. № 3. P. 425–430.; Victor M., Adams R.D. On the etiology of the alcoholic neurologic diseases. With special references to the role of nutrition // Am. J. Clin. Nutr. 1961. Vol. 9. P. 379–383.; Wang Z.B., Gan Q., Rupert R.L., Zeng Y.M., Song X.J. Thiamine, pyridoxine, cyanocobalamin and their combinatuin inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron loss // Pain. 2005. Vol. 114. P. 266–277.; Wang H.S., Kuo M.F. Vitamin B6 related epilepsy during childhood // Chang Gung Med. J. 2007. Vol. 30. № 5. P. 396–401.; Zambelis T., Karandreas N., Tzavellas E. et al. Large and small fiber neuropathy in chronic alcohol-dependent subject // J. Periph. Nerv. Sys. 2005. Vol. 10. P. 375–38.; https://www.medarhive.ru/jour/article/view/13
-
19Academic Journal
Authors: Гурьева, И.
Subject Terms: САХАРНЫЙ ДИАБЕТ, ДИАБЕТИЧЕСКАЯ НЕВРОПАТИЯ, ХРОНИЧЕСКАЯ БОЛЬ, ИНГИБИТОР ДВОЙНОГО ДЕЙСТВИЯ
File Description: text/html
-
20Academic Journal
Source: Нервные болезни.
Subject Terms: САХАРНЫЙ ДИАБЕТ,ДИАБЕТИЧЕСКАЯ НЕВРОПАТИЯ,НЕЙРОМЕТАБОЛИЧЕСКИЕ ПРЕПАРАТЫ,ТИОКТОВАЯ КИСЛОТА
File Description: text/html
